Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_019d4481a09e99aa635a15f4d07f44a8 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-24 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 |
filingDate |
2004-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2008-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e540dc5802a8b5f28c8f8af0085a42b6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_168005e3eedccfc32ebedfc536c7aac2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6bdbfd918213205408db2018b7fdb4a6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc22863fb1d96b15c3346e1d3aa24e86 |
publicationDate |
2008-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
RU-2341530-C2 |
titleOfInvention |
Thermostable crystal epirubicine hydrochloride and method of production thereof |
abstract |
FIELD: medicine; pharmacology. n SUBSTANCE: crystal epirubicine hydrochloride of type II has diffraction pattern of X-ray powder scattering providing average diffraction angles (2θ) and relative intensities P(%), presented in the Table indicated below: n n n n EFFECT: effective application of new crystal form for cancer treatment in people and animals. n 6 cl, 7 dwg, 4 tbl, 6 ex |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2700683-C2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2586117-C2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2630692-C2 |
priorityDate |
2003-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |